Newborn Screening for Pompe Disease by Measuring Acid α-Glucosidase Activity Using Tandem Mass Spectrometry
Authors:
- 1 October 2008
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 54 (10) , 1624-1629
Abstract
Background: Pompe disease, caused by the deficiency of acid α-glucosidase (GAA), is a lysosomal storage disorder that manifests itself in its most severe form within the first months of life. Early detection by newborn screening is warranted, since prompt initiation of enzyme replacement therapy may improve morbidity and mortality. We evaluated a tandem mass spectrometry (MS/MS) method to measure GAA activity for newborn screening for Pompe disease.Keywords
This publication has 12 references indexed in Scilit:
- Multiplex Enzyme Assay Screening of Dried Blood Spots for Lysosomal Storage Disorders by Using Tandem Mass SpectrometryClinical Chemistry, 2008
- Early Detection of Pompe Disease by Newborn Screening Is Feasible: Results From the Taiwan Screening ProgramPediatrics, 2008
- Recombinant human acid α-glucosidaseNeurology, 2007
- Influence of hematocrit and localisation of punch in dried blood spots on levels of amino acids and acylcarnitines measured by tandem mass spectrometryClinica Chimica Acta, 2006
- Newborn screening for lysosomal storage disordersMolecular Genetics and Metabolism, 2006
- Chinese hamster ovary cell-derived recombinant human acid α-glucosidase in infantile-onset Pompe diseaseThe Journal of Pediatrics, 2006
- Direct multiplex assay of enzymes in dried blood spots by tandem mass spectrometry for the newborn screening of lysosomal storage disordersJournal of Inherited Metabolic Disease, 2006
- Newborn Screening for Lysosomal Storage Disorders: Clinical Evaluation of a Two-Tier StrategyPediatrics, 2004
- Direct Multiplex Assay of Lysosomal Enzymes in Dried Blood Spots for Newborn ScreeningClinical Chemistry, 2004
- Glycogen storage disease type II: enzymatic screening in dried blood spots on filter paperClinica Chimica Acta, 2004